Bleeding and Platelet Disorders
Gene: FGAEnsemblGeneIds (GRCh38): ENSG00000171560
EnsemblGeneIds (GRCh37): ENSG00000171560
OMIM: 134820, Gene2Phenotype
FGA is in 9 panels
2 reviews
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)
Bleeding due to afibrinogenaemia usually manifests in the neonatal period, with 85% of cases presenting umbilical cord bleeding, but a later age of onst is not unusual. Bleeding may occur in the skin, gastrointestinal tract, genitourinary tract, or the central nervous system, with intracranial haemorrhage being reported as the major cause of death. Patients are susceptible to spontaneous rupture of the spleen.
Monoallelic variants in this gene are associated with amyloidosis.
- Premature termination variants (PTVs) located downstream of ~p.500 are associated with autosomal dominant familial visceral amyloidosis (MIM#105200). PTVs located upstream are associated with autosomal recessive congenital afibrinogenemia (MIM#202400). (PMIDs: 31064749, 17295221, 19073821)
- Biallelic loss of function result in congenital afibrinogenemia (MIM#202400) (PMID:17295221). The disease mechanism of autosomal dominant familial visceral amyloidosis (MIM#105200) is unclear.
- PMID:11739173 concluded that null mutants of congenital afibrinogenemia (AR) patients escaped NMD.Created: 18 May 2021, 1:06 a.m. | Last Modified: 18 May 2021, 1:06 a.m.
Panel Version: 0.220
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Afibrinogenemia, congenital (MIM#202400)
Publications
Chern Lim (Victorian Clinical Genetics Services)
- Premature termination variants (PTVs) located downstream of ~p.500 are associated with autosomal dominant familial visceral amyloidosis (MIM#105200). PTVs located upstream are associated with autosomal recessive congenital afibrinogenemia (MIM#202400). (PMIDs: 31064749, 17295221, 19073821)
- Biallelic loss of function result in congenital afibrinogenemia (MIM#202400) (PMID:17295221). The disease mechanism of autosomal dominant familial visceral amyloidosis (MIM#105200) is unclear.
- PMID:11739173 concluded that null mutants of congenital afibrinogenemia (AR) patients escaped NMD.Created: 17 May 2021, 10:02 a.m. | Last Modified: 17 May 2021, 10:02 a.m.
Panel Version: 0.7637
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Afibrinogenemia, congenital (MIM#202400), AR; Amyloidosis, familial visceral (MIM#105200), AD
Publications
Variants in this GENE are reported as part of current diagnostic practice
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- Expert Review Green
- Victorian Clinical Genetics Services
- Phenotypes
-
- Afibrinogenemia, congenital (MIM#202400)
- OMIM
- 134820
- Clinvar variants
- Variants in FGA
- Penetrance
- None
- Publications
- Panels with this gene
History Filter Activity
Entity classified by Genomics England curator
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Gene: fga has been classified as Green List (High Evidence).
Set Phenotypes
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Phenotypes for gene: FGA were changed from to Afibrinogenemia, congenital (MIM#202400)
Set publications
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Publications for gene: FGA were set to
Set mode of inheritance
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Mode of inheritance for gene: FGA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
Created, Added New Source, Set mode of inheritance
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)gene: FGA was added gene: FGA was added to Bleeding Disorders_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: FGA was set to Unknown